A 9-month-old Ethiopian child recieving a measels vaccination WIKIMEDIA, PETE LEWIS / DFID
An experimental vaccine reduced the risk of developing malaria by about 50 percent in 6,000 sub-Saharan African children when combined with existing interventions, such as the use of insecticide-treated bed nets, according to a new study published online today by the New England Journal of Medicine.
Officials and researchers collaborating on the project announced preliminary results from the Phase III clinical trial of the RTS,S malaria vaccine today (18 October) at a malaria meeting in Seattle. "We're on track to make history with this vaccine trial," Christopher Elias, president and CEO of the Seattle-based nonprofit PATH organization, which collaborated in the trial, said during the news conference.
Doctors at 11 sites spread across seven African nations administered three successive doses of the RTS,S vaccine to ...
